-
ASSESSING GENERIC PREFERENCE-BASED MEASURES FOR PROGRESSIVE SUPRANUCLEAR PALSY: A CONCEPT MAPPING APPROACH
Mar 18, 2026, 21:38 PM -
CHARACTER STRENGTHS AND BURNOUT DIMENSIONS AMONG EMERGENCY CARE PROFESSIONALS IN HUNGARY: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN US PLATINUM-RESISTANT OVARIAN CANCER PATIENTS: CHARACTERIZING THE UNMET CLINICAL NEED
Mar 18, 2026, 21:38 PM -
FROM RETRIEVAL TO VERDICT: A HYBRID LLM PIPELINE FOR EVALUATING MEDICAL AND ECONOMIC CLAIMS
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE IMPACT AND BURDEN OF MENOPAUSE ON MULTIPLE SCLEROSIS THROUGH A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
FIRST-LINE SYSTEMIC TREATMENT PATTERNS IN METASTATIC UROTHELIAL CARCINOMA IN US COMMUNITY ONCOLOGY PRACTICES
Mar 18, 2026, 21:38 PM -
UTILIZATION AND CLINICAL OUTCOMES OF DIRECT ORAL ANTICOAGULANTS IN REAL-WORLD SETTINGS: EVIDENCE FROM A GLOBAL FEDERATED RESEARCH NETWORK IN EUROPE
Mar 18, 2026, 21:38 PM -
METHODOLOGICAL CHARACTERISTICS OF PHARMACOGENOMICS-INTEGRATED AI CLINICAL DECISION SUPPORT SYSTEMS (AI-CDSS): A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF AN AI-POWERED CLINICAL PHARMACIST ASSISTANT FOR PREDICTING ADVERSE DRUG REACTIONS IN INDIAN HOSPITALS
Mar 18, 2026, 21:38 PM -
A METHODOLOGICAL REVIEW OF VALUATION STUDIES FOR THE EQ-5D-5L: EVOLVING PRACTICES AND LESSONS FROM THE EQ-5D-3L
Mar 18, 2026, 21:38 PM -
THE SIMULATION MODEL FOR INTERVENTIONS LINKING EVIDENCE TO SOCIAL DETERMINANTS OF HEALTH (SMILES): A PLATFORM FOR EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF LOCAL AND STATE POLICIES FOR CHRONIC DISEASE PREVENTION
Mar 18, 2026, 21:38 PM -
TEPROTUMUMAB VERSUS INTRAVENOUS METHYLPREDNISOLONE ALONE, AND IN COMBINATION WITH MYCOPHENOLATE MOFETIL, FOR MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE: A MATCHING-ADJUSTED INDIRECT COMPARISON
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE HUMANISTIC BURDEN OF SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
COGNITIVE IMPAIRMENT AND MEDICATION ADHERENCE IN PATIENTS WITH CORONARY ARTERY DISEASE: A PROSPECTIVE COHORT STUDY USING MOCA AND ACDS
Mar 18, 2026, 21:38 PM -
IMPUTING MISSING DATA IN OBSERVATIONAL STUDIES: WHAT METHODS ARE BETTER?
Mar 18, 2026, 21:38 PM -
OPERATIONALIZING PATIENT ENGAGEMENT IN RARE DISEASE VALUE RESEARCH LESSONS FROM DISEASE-SPECIFIC USE CASES
Mar 18, 2026, 21:38 PM -
ESTIMATING THE COST OF ORPHAN DRUG TREATMENT FROM THE PERSPECTIVE OF MEXICO'S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF HARTC 2.0 TRIAL: PREHOSPITAL ACS TRIAGE USING A MODIFIED HEART SCORE WITH POINT-OF-CARE HS-CTNI
Mar 18, 2026, 21:38 PM -
PORTABILITY OF PERFORMANCE STATUS CALCULATIONS IN REAL-WORLD CANCER CARE
Mar 18, 2026, 21:38 PM -
EVALUATING THE QUALITY OF CLINICAL EVIDENCE FOR DIGITAL HEALTH SOLUTIONS ACROSS FIVE THERAPEUTIC AREAS: FINDINGS FROM PHTI ASSESSMENTS
Mar 18, 2026, 21:38 PM
